Natus Medical Incorporated (NTUS) Misses Q4 EPS by 1c, Offers Guidance

Natus Medical Incorporated (NASDAQ: NTUS) reported Q4 EPS of $0.46, $0.01 worse than the analyst estimate of $0.47. Revenue for the quarter came in at $131.8 million versus the consensus estimate of $130 million.

GUIDANCE:

Natus Medical Incorporated sees Q1 2020 EPS of $0.19-$0.25. Natus Medical Incorporated sees Q1 2020 revenue of $113-117 million.

Natus Medical Incorporated sees FY2020 EPS of $1.45-$1.55. Natus Medical Incorporated sees FY2020 revenue of $480-490 million.

For earnings history and earnings-related data on Natus Medical Incorporated (NTUS) click here.

You May Also Be Interested In

• Opera Limited (OPRA) Misses Q2 EPS by 1c ; Offers Guidance
• Estee Lauder (EL) Tops Q4 EPS by 7c, Beats on Revenue
• Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance